Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with 1
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| 1-(PHENYLAZO)-2-NAPHTHYLAMINE | ORAL | CAPSULE | 85847 | 3VSI4D701X | 0.13mg | ||
| 1-(PHENYLAZO)-2-NAPHTHYLAMINE | ORAL | TABLET | 85847 | 3VSI4D701X | 0.2mg | ||
| 1,2,6-HEXANETRIOL | TOPICAL | CREAM | 106694 | W45XXM0XWE | 43mg | ||
| 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 816944 | 043IPI2M0K | 2.8%w/v | ||
| 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | INTRAVENOUS | INJECTION | 816944 | 043IPI2M0K | 68mg | ||
| 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | RESPIRATORY (INHALATION) | CAPSULE | 816944 | 043IPI2M0K | 51mg | ||
| 1,4-SORBITAN | ORAL | CAPSULE | 27299123 | AV0YTZ4E6J | 242mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024